138 related articles for article (PubMed ID: 7959287)
1. Salvage surgery for chemorefractory ovarian germ cell tumors.
Munkarah A; Gershenson DM; Levenback C; Silva EG; Messing MJ; Morris M; Burke TW
Gynecol Oncol; 1994 Nov; 55(2):217-23. PubMed ID: 7959287
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
3. Outcome and prognostic factors in ovarian germ cell malignancies.
Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN
Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426
[TBL] [Abstract][Full Text] [Related]
4. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
5. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
6. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
7. Prolonged survival following salvage surgery for chemorefractory ovarian immature teratoma: a case report and review of the literature.
Rezk Y; Sheinfeld J; Chi DS
Gynecol Oncol; 2005 Mar; 96(3):883-7. PubMed ID: 15721445
[TBL] [Abstract][Full Text] [Related]
8. Malignant ovarian germ cell tumor in King Chulalongkorn Memorial Hospital.
Lertkhachonsuk R; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Tresukosol D
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S124-8. PubMed ID: 16623016
[TBL] [Abstract][Full Text] [Related]
9. Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital.
Lertkhachonsuk R; Manchana T; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Sirisabya N; Khemapech N; Tresukosol D
J Med Assoc Thai; 2006 Feb; 89(2):138-44. PubMed ID: 16578998
[TBL] [Abstract][Full Text] [Related]
10. Laparotomy for post chemotherapy residue in ovarian germ cell tumors.
Mathew GK; Singh SS; Swaminathan RG; Tenali SG
J Postgrad Med; 2006; 52(4):262-5. PubMed ID: 17102543
[TBL] [Abstract][Full Text] [Related]
11. Malignant ovarian germ cell tumors: a single-institution experience.
Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
[TBL] [Abstract][Full Text] [Related]
12. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
[TBL] [Abstract][Full Text] [Related]
13. A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.
Kesler KA; Rieger KM; Hammoud ZT; Kruter LE; Perkins SM; Turrentine MW; Schneider BP; Einhorn LH; Brown JW
Ann Thorac Surg; 2008 Feb; 85(2):371-8. PubMed ID: 18222228
[TBL] [Abstract][Full Text] [Related]
14. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients.
Ogawa K; Toita T; Nakamura K; Uno T; Onishi H; Itami J; Shikama N; Saeki N; Yoshii Y; Murayama S
Cancer; 2003 Jul; 98(2):369-76. PubMed ID: 12872359
[TBL] [Abstract][Full Text] [Related]
15. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?
Zang RY; Li ZT; Tang J; Cheng X; Cai SM; Zhang ZY; Teng NN
Cancer; 2004 Mar; 100(6):1152-61. PubMed ID: 15022281
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary.
Kumar S; Shah JP; Bryant CS; Imudia AN; Cote ML; Ali-Fehmi R; Malone JM; Morris RT
Gynecol Oncol; 2008 Aug; 110(2):125-32. PubMed ID: 18571705
[TBL] [Abstract][Full Text] [Related]
17. [Lymphadenectomy in the treatment of malignant ovarian germ cell tumor].
Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):743-8. PubMed ID: 16447650
[TBL] [Abstract][Full Text] [Related]
18. Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive ovarian cancer.
Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Blumenson LE
Gynecol Oncol; 1998 Nov; 71(2):190-5. PubMed ID: 9826459
[TBL] [Abstract][Full Text] [Related]
19. Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary.
Nishio S; Ushijima K; Fukui A; Fujiyoshi N; Kawano K; Komai K; Ota S; Fujiyoshi K; Kamura T
J Obstet Gynaecol Res; 2006 Aug; 32(4):416-21. PubMed ID: 16882268
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]